Lung Cancer Clinical Trials in New York, NY

Lung Cancer Clinical Trials in New York, NY

View the best 10 lung cancer medical studies in New York, New York. Access promising new therapies by applying to a New York-based Lung Cancer clinical trial.

Trials in New York, New York

Here are the top 10 medical studies for lung cancer in New York, New York

Image of Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities) in Basking Ridge, United States.

ado-trastuzumab emtansine

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it can help people with cancer that has come back or spread, and that has the HER2 gene.
Image of Miami Cancer Institute in Miami, United States.

Fractionated Stereotactic Radiation Therapy +1 More

Radiation

Recruiting2 awardsPhase 3
This trial compares two types of radiation therapy for treating cancer that has spread to the brain. One type, called fractionated stereotactic radiosurgery (FSRS), delivers a high dose of radiation over
Image of City of Hope Cancer Center in Duarte, United States.

Tepotinib

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will study the effects of tepotinib on lung cancer growth and spread, as well as safety, side effects, and quality of life. Pharmacogenetic research may also be conducted to study how genes impact the effectiveness of the drug.
Image of University of Florida Health Science Center - Jacksonville in Jacksonville, United States.

Proton Beam Radiation Therapy +1 More

Proton Beam Therapy

Recruiting3 awardsPhase 3
This trial is comparing two types of radiation therapy to see which is more effective in treating patients with stage II-IIIB non-small cell lung cancer- proton chemoradiotherapy versus photon chemoradiotherapy.
Image of University of South Alabama, Mitchell Cancer Institute ( Site 0003) in Mobile, United States.

Carboplatin +6 More

Platinum-based Chemotherapy

Recruiting1 awardPhase 3
This trial will compare the efficacy of three different treatments for unresectable, locally advanced NSCLC. Arm 1 will receive pembrolizumab concurrently with chemoradiation, followed by pembrolizumab with olaparib placebo. Arm 2 will receive the same treatment as Arm 1, but will take olaparib instead of the placebo. Arm 3 will receive concurrent chemoradiation therapy followed by durvalumab. The primary hypothesis is that pembrolizumab with concurrent chemoradiation and olaparib is superior to durvalumab with respect to PFS and OS.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Arizona Oncology Associates, PC- HAL ( Site 8001) in Tempe, United States.

Lenvatinib +3 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing different combinations of cancer drugs to find the best treatment for patients with advanced lung cancer who haven't been treated before. The drugs help the immune system fight cancer or stop the cancer cells from growing.
Image of University of Alabama -Birmingham in Birmingham, United States.

Ifinatamab deruxtecan +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
"This trial aims to test if a new drug called ifinatamab deruxtecan, when combined with another drug atezolizumab, is safe and effective in treating small cell
Image of Research Site in Anchorage, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 3
This trial will study whether osimertinib can prevent recurrence of EGFRm non-small cell lung cancer in people who have had surgery to remove the tumor.
Image of City of Hope National Medical Center in Duarte, United States.

VMD-928

Small Molecule Inhibitor

Recruiting1 awardPhase 1
This trial tests VMD-928, an oral drug, in adults with advanced cancers that don't respond to other treatments. It aims to find a safe and effective dose and understand how the drug affects cancer cells.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.